Introduction
============

*Helicobacter pylori* is a Gram-negative bacterium that infects more than half of the world's population and it is the major cause of gastroduodenal diseases, such as gastritis, peptic ulcers, and gastric cancer ([@B24]). *H. pylori* infection was responsible for 770,000 new cases of gastric cancer worldwide in 2012 ([@B54]). Gastric cancer is the third most common cause of cancer-related deaths worldwide according to GLOBOCAN 2012 database, and risk factors include smoking, obesity, diet and bacterial infections, most importantly, *H. pylori* infection ([@B14]).

This bacterium produces large amounts of urease, an important virulence factor involved in a series of processes that allow bacteria to colonize and induce a strong inflammatory response in the gastric epithelium. HPU enzymatic activity causes hydrolysis of urea into ammonia, thereby neutralizing the acid environment of the stomach ([@B44]), leading to altered properties of the gastric mucous layer ([@B52]). HPU is a large protein, consisting of a dodecameric organization of two subunits (UreA, 26.5 kDa; UreB, 61.7 kDa; [@B20]). Its smaller subunit UreA was found to localize in the nuclei of cultured gastric epithelial cells, leading to altered morphology of AGS cells ([@B34], [@B35]). Additionally, both HPU subunits, UreA and UreB, were observed inside outer membrane vesicles secreted by *H. pylori* and vesicles derived from pathogenic bacteria are often involved in toxin delivery to the host ([@B50]). By a mechanism not yet fully understood, HPU is also involved in the dysregulation of gastric epithelial tight junctions ([@B67]) and independently of its enzyme activity, it promotes activation of neutrophils both *in vivo* and *in vitro* conditions ([@B64]; [@B3]).

Angiogenesis, the formation of new blood vessels from the pre-existing vasculature, is essential for tumor growth, invasion, and metastatic dissemination and it plays a central role in the progression of gastric cancer by providing nutrients and oxygen ([@B21]; [@B13]; [@B41]). *H. pylori* infection can induce and modulate the synthesis of angiogenic and invasive factors in gastric cancer cells ([@B29]), and gastritis *H. pylori*-positive patients have an increased number of blood vessels in the gastric mucosa compared to *H. pylori*-negative patients ([@B68]). Recently, [@B40] showed that *H. pylori* colonization correlated to the depth of tumor invasion and higher stage metastasis. VEGF is overexpressed in *H. pylori*-positive patients and gastric cancer tumors ([@B47]). However, VEGF overexpression is a poor prognosis indicator of increased angiogenesis in gastric cancer, suggesting that different factors may be involved in this process ([@B53]).

Here, we seek to investigate whether HPU plays a role in the angiogenesis process induced by *H. pylori*.

Materials and Methods {#s1}
=====================

Cell Culture
------------

Human AGS (ATCC^®^CRL-1739^TM^), AGS-Ecad ([@B48]), Kato-III (ATCC^®^HTB-103^TM^), MKN28 (JCRB0253^TM^) were maintained in RPMI 1640 medium with GlutaMAX^TM^ (Invitrogen, Thermo Fisher Scientific, Inc., Waltham, MA, United States) supplemented with 10% fetal bovine serum (FBS, HyClone^TM^, GE Healthcare Life Sciences, Logan, UT, United States), 200 IU/mL penicillin G-200 μg/mL streptomycin sulfate (Invitrogen) at 37°C under 5% CO~2~ humidified atmosphere. Human umbilical vein endothelial cells (HUVECs; HUV-EC-C, ATCC^®^CRL1730^TM^) were maintained in Medium 199 (M199) with Earle's salts, stable glutamine, and 25 mM HEPES buffer (Biowest, Nuaillé, France) supplemented with 10% FBS, 100 IU-100 μg/mL Penicillin G-Streptomycin Sulfate (Gibco), 100 μg/mL Heparin (Sigma--Aldrich, St. Louis, MO, United States), and 30 μg/mL Endothelial Mitogen (ECGS) (BioMedical Technologies, Inc., Stoughton, MA, United States), in gelatin-coated (Sigma--Aldrich, St. Louis, MO, United States) tissue-culture Petri dishes (TPP^®^ Plastic Products AG, Trasadingen, Switzerland), at 37°C under 5% CO~2~ humidified atmosphere.

Bacterial Strain and Growth Conditions
--------------------------------------

Bacteria were grown for 48 h at 37°C under a microaerophilic atmosphere (GENbox microaer; bioMérieux S.A., Marcy l'Etoile, France) in Trypticase^TM^ Soy Agar with 5% sheep blood (TSAII; Becton, Dickinson and Company, Franklin Lakes, NJ, United States). Experiments were performed with *H. pylori* strain 26695 (ATCC^®^700392^TM^; *cag* PAI^+^).

HPU Purification
----------------

*Helicobacter pylori* bacteria grown for 48 h in TSAII (40 plates) were harvested in phosphate buffer (20 mM NaH~2~PO~4~, pH 7.5) and lysed by ultrasound (Ultrasonic Homogenizer 4710; 10 pulses of 30 s in ice bath). After centrifugation (20 min, 20,000 × *g*, 4°C), the supernatant was processed according to a previously published protocol to obtain purified HPU ([@B66]). Protein purity was assessed by gel electrophoresis in 10% polyacrylamide gels containing 0.1% sodium dodecyl sulfate (SDS-PAGE).

Immunofluorescence and Microscopy
---------------------------------

Immunofluorescence studies and analysis by laser scanning confocal microscopy were performed using a PL APO 63× NA 1.40 oil objective (Spectral Confocal Microscope Leica TCS-SP5; Leica Microsystems, Mannheim, Germany). The images were combined and merged using ImageJ ([@B56]) with the plugin Bio-Formats ([@B39]). For immunocytochemistry, after treatment with 100 nM HPU for 5, 15, and 45 min, the AGS cells were fixed with 4% paraformaldehyde (Polysciences, Warrington, PA, United States), washed with phosphate buffered saline (PBS), and permeabilized with ice-cold 100% methanol. Cells were incubated with the primary rabbit polyclonal antibody anti-UreB and mouse monoclonal antibody anti-Early Endosome Antigen 1 (EEA1) (Santa Cruz Biotechnology, Dallas, TX, United States). The secondary antibodies Alexa Fluor 488 goat anti-rabbit IgG and Alexa Fluor 596 goat anti-mouse (Thermo Fisher Scientific) were used to monitor the location of UreB and EEA1. 4′,6-diamidino-2-phenylindole (DAPI) was used to visualize the nuclei (0.1 mg/mL, Molecular Probes, Eugene, OR, United States).

For live cell experiments, AGS cells were previously transfected with Lamp1-GFP (donated by Dr. Allan Levey, Emory University) using Lipofectamine 2000 transfection reagent (Invitrogen) according to manufacturer's recommendations. HPU was covalently tagged with Texas Red (Sulforhodamine 101 acid chloride; Sigma--Aldrich).

*Helicobacter pylori* urease incubated with Texas Red (0.5 mg/mL) during 1 h, at 4°C, with continuous stirring. This sample was then exhaustively dialyzed against 20 mM phosphate buffer, pH 7.0, and gel-filtrated using a De-Salting column (Sigma--Aldrich) to remove any excess of free dye.

Cholesterol Depletion
---------------------

Cholesterol was depleted in AGS cells by incubation with 5 mg/mL mβCD (Sigma--Aldrich) in serum-free medium at 37°C under 5% CO~2~ for 60 min ([@B23]). This treatment did not affect cell viability as assessed by the trypan blue exclusion test ([@B60]).

Cell Viability Assay
--------------------

The viability of the gastric epithelial cells upon HPU treatment was evaluated using the MTT assay 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (M2128) (Sigma--Aldrich), according to manufacturer's instructions. Cells were seeded at a density of 1.5 × 10^5^ cells/well in 96-well plates, and then incubated with 300 nM HPU or PBS for 24 h. After incubation, 20 μL of MTT solution (5 mg/mL) was added to each well and incubated for 150 min at 37°C. The media was carefully removed and 150 μL MTT solvent (4 mM HCl, 0.1% NP40, in isopropanol) was added to the wells. The absorbance was measured at 570 nm in a plate reader (SpectraMax M3, Molecular Devices, Sunnyvale, CA, United States). The experiments were performed in triplicates.

Analysis for Apoptosis-Related Proteins by Western Blot
-------------------------------------------------------

Two different administrations schedules were used for HPU incubation in AGS cells. To investigate an "acute" effect of the protein, two doses of 300 nM HPU were added to the medium at 0 and 2 h, and the experiment was concluded after 6 h of total incubation. To simulate a "chronic" effect, cells received three doses of HPU, with additions of freshly diluted HPU (300 nM) at 0, 6 and 24 h time-points and the experiment was terminated after 48 h. Cell lysates from both groups were prepared, denatured in sample buffer (50 mM Tris-HCl, pH 6.8, 1% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.001% bromophenol blue) and heated in a boiling water bath for 3 min. Samples (30 μg total protein) were resolved in 10% SDS-PAGE gels and proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Hybond-P, Amersham Pharmacia Biotech). Rainbow markers (Thermo Fisher Scientific, Inc.) were run in parallel to estimate molecular masses. Membranes were blocked with Tween-Tris buffered saline (TBS) (20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.1% Tween-20) containing 1% bovine serum albumin (BSA) and probed with rabbit monoclonal antibodies: anti-Bcl-X~L~ (Cell Signaling Technology, Danvers, MA, United States, 1:500) and anti-BAD (Cell Signaling Technology, 1:500). Secondary antibodies (anti-rabbit, 1:20,000) coupled to horseradish peroxidase were from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA, United States). The protein bands were visualized using a chemiluminescence detection kit (Millipore, Billerica, MA, United States). The levels of protein expression were quantified using the software ImageJ and normalized against β-actin as an endogenous control.

Human Angiogenesis-Related Proteins
-----------------------------------

The Human Angiogenesis Array Kit (Proteome Profiler^TM^- ARY007 Array, R&D Systems, Inc., Minneapolis, MN, United States) was used to detect the expression of angiogenesis-related proteins in cellular extracts from AGS cells treated with 300 nM HPU for 9 h in comparison with PBS-treated cells, as control. The array was performed once according to manufacturer's instructions, using a pool of cellular lysates from three independent experiments, containing 300 μg of total protein.

Endothelial Cell Capillary-Like Tube Formation Assay
----------------------------------------------------

Human umbilical vascular endothelial cells were seeded in 96-wells plates coated with 100 μL of growth factor-reduced Matrigel^TM^ (Corning^®^Inc., Tewksbury, MA, United States) in serum-free RPMI 1640 GlutaMax medium (Gibco) at a density of 6 × 10^4^ cells per well in the presence of 300 nM HPU or PBS (control) for a total of 9 h. HUVECs were allowed to stabilize for 3 h in a cell culture incubator at 37°C with 5% CO~2~ humidified atmosphere. The formation of endothelial network was then followed in the center of each well using a Leica DMI 6000 time-lapse microscope (Leica Microsystems, Germany) for 6 h, with a 10x magnification and z-stacks of 2.08 μm were acquired every 30 min. The number of tubes and branching points per microscopic field were automatically quantified using Angiogenesis analyzer plugin ([@B4]) for ImageJ software ([@B56]).

Chicken Embryo Chorioallantoic Membrane Angiogenesis Assay
----------------------------------------------------------

The chicken embryo CAM model was used to evaluate angiogenic activity of HPU as previously described ([@B62]). HPU (50 nM, *N* = 16; 100 nM, *N* = 12 and 500 nM, *N* = 14), 2.78 μM of b-FGF2 (positive control, *N* = 14) and PBS/vehicle (negative control, *N* = 16) were tested. Briefly, fertilized chick (*Gallus gallus*) eggs obtained from commercial sources were incubated horizontally at 37.8°C in a humidified atmosphere and referred as embryonic day (E). On E3, a square window was opened in the shell after removal of 2--2.5 mL of albumen to allow detachment of the developing CAM. The window was sealed with a transparent adhesive tape and the eggs returned to the incubator. On E10, 10 μL of test solution were placed on the top of growing CAM into a 3 mm silicon ring under sterile conditions. The eggs were re-sealed and returned to the incubator for three more days. After removing the ring, the CAM was excised from the embryos, photographed *ex ovo* under a stereoscope, at 20x magnification (Olympus, SZX16 coupled with a DP71 camera). The number of new vessels (less than 15 μm diameter) growing radially toward the ring area was counted in a blind fashion manner. Statistical analysis was performed as described below.

Statistical Analysis
--------------------

The statistical significance of the differences between two groups was assessed using the unpaired Student's *t*-test and for multiple comparisons it was performed a two-way analysis of variance (ANOVA) followed by Dunnett's multi-comparison post hoc test, used to calculate significance. GraphPad Prism6 software (San Diego, CA, United States) was used to perform statistical analysis. Statistically significance was set at p-value ≤ 0.05. Data in graphs represent average ± standard error of the mean (SEM) of at least three experiments, unless otherwise stated.

Results
=======

HPU Is Not Cytotoxic to Gastric Epithelial Cells
------------------------------------------------

To address whether purified HPU could affect cell proliferation and viability of gastric epithelial cell lines we performed the MTT cell proliferation assay. The incubation of AGS, Kato-III, and MKN28 cells with 300 nM HPU for 24 h does not interfere with the proliferation rate, nor with the cell viability of gastric cell lines, as indirectly measured in the MTT assay (**Figure [1A](#F1){ref-type="fig"}**). Further, the levels of Bcl-X~L~, an anti-apoptotic protein, and the levels of BAD, a pro-apoptotic protein, were evaluated by western blot in AGS cells after incubation with HPU under two experimental conditions. One of them aimed to simulate an "acute" effect of HPU (6 h of treatment), and the other a "chronic" effect (48 h of treatment) (**Figures [1B,C](#F1){ref-type="fig"}**). HPU induced a significant decrease in the expression levels of BAD in both "acute" and "chronic" conditions when compared to untreated cells, of 55 and 80%, respectively. The levels of Bcl-X~L~, on the other hand, increased almost 100% relative to untreated cells, but only in the "acute" model of stimulation.

![*Helicobacter pylori* urease is not cytotoxic to gastric epithelial cell lines. **(A)** Effect of HPU in cell proliferation and viability of AGS, Kato-III, and MKN28 cell lines incubated with 300 nM HPU or PBS for 24 h, was evaluated by the MTT assay. **(B)** Levels of pro- and anti-apoptotic proteins in AGS cells treated with daily freshly added 300 nM HPU for 6 h ("acute" exposure), and for 48 h ("chronic" exposure). **(C)** Cell lysates were analyzed for the cytoplasmic content of BAD (left panel) and Bcl-X~L~ (right panel) by Western blot. Results shown are means ± SEM, *N* = 3; ^∗^*p* ≤ 0.05 was considered statistically significant.](fmicb-08-01883-g001){#F1}

HPU Is Internalized by Gastric Epithelial
-----------------------------------------

To explore if HPU is internalized by gastric epithelial cells, we treated AGS cells with HPU and performed confocal immunofluorescence microscopy. After 15 min of incubation, HPU detected with an anti-UreB antibody and an Alexa-488-conjugated secondary antibody was found on the plasma membrane, and some molecules were already in the cytoplasm (**Figure [2A](#F2){ref-type="fig"}**). After 45 min post-stimulation, HPU was still seen in a specific area of the plasma membrane (**Figure [2B](#F2){ref-type="fig"}**), suggesting that the internalization process may occur via specific receptors or cellular structures. Next, to gain insight of HPU's internalization route, AGS cells were analyzed at shorter periods of treatment for co-localization of HPU and early endosomes, by confocal immunofluorescence microscopy. As shown in **Figures [2C,D](#F2){ref-type="fig"}**, during the initial steps of internalization HPU co-localizes with EEA1-positive early endosomes. After 10 min, a co-localization with Lamp1 was observed, suggesting the progression of HPU sorting to late endosomes/lysosomes (**Figures [2E,F](#F2){ref-type="fig"}**).

![Internalization of HPU by gastric epithelial cells occurs through a classic endocytic pathway and is dependent on cholesterol. **(A,B)** Confocal immunofluorescence microscopy showing internalization of HPU in AGS cells treated with 100 nM HPU. Cells were fixed, permeabilized and processed for the detection of HPU, using an antibody against urease (Ure-B subunit) stained with Alexa-488-conjugated secondary antibody (green), and for the detection of early endosomes, using an antibody for EEA-1 with Alexa-596-conjugated antibody (red). A representative result is shown for cells fixed after 15 min **(A)** and after 45 min **(B)** of treatment with HPU, at 37°C. **(C,D)** Colocalization (yellow) of HPU (green) and EEA1-positive endosomes (red) in AGS cells treated with HPU for 5 min at 37°C evaluated by confocal microscopy. **(C,D)** Show different sections of the same cell agglomerate. Inserts are 100x original magnifications depicting EEA1-positive endosomes (anti-EEA-1 antibody and Alexa-596 secondary antibody) containing HPU (anti-UreB antibody labeled with Alexa-488 secondary antibody) next to the plasma membrane. **(E--G)** Endocytosis of HPU involves Lamp1-positive endosomes and is impaired upon cholesterol depletion. **(E,F)** AGS cells were transfected with a Lamp1-GFP plasmid prior to the addition of TexasRed-labeled HPU at 100 nM. **(G,H)** Transfected cells were pre-treated with 5 mg/mL mβCD, for 1 h, washed, and then treated with 100 nM TexasRed-labeled HPU. After approximately 1 min of contact of the cells with HPU, the detection of fluorescence by confocal microscope was started and the time point called 0 min. Scale bars 10 μm.](fmicb-08-01883-g002){#F2}

In order to investigate the involvement of cholesterol in the binding and endocytosis of HPU, AGS cells were treated with mβCD, a cholesterol scavenger, previously to treatment with HPU. **Figures [2G,H](#F2){ref-type="fig"}** show that binding of HPU to the cell membrane depends on cholesterol, suggesting that HPU internalization probably occurs through cholesterol-rich plasma membrane structures, such as lipid rafts.

HPU Induces Angiogenesis
------------------------

To investigate the involvement of HPU in angiogenesis we performed the endothelial cell tube formation assay. The addition of 300 nM HPU induced the formation of tube-like structure by HUVECs, after 9 h of treatment (**Figure [3A](#F3){ref-type="fig"}**). Quantification of the total number of tubes and branching points per microscopic field showed a significantly higher number of both structures in HPU-treated HUVECs than in control, the PBS-treated HUVECs (**Figure [3B](#F3){ref-type="fig"}**).

![*Helicobacter pylori* urease induces an angiogenic response both *in vitro* and *in vivo* models. **(A,B)** Effect of HPU in the induction of tube-like structures by HUVECs. **(A)** Representative micrographs showing the endothelial network formed by HUVECs exposed to 300 nM HPU after 9 h of treatment in comparison with that of untreated cells. **(B)** Quantification of the number of nodes and branches points formed per microscopic field of three independent experiments, using the plugin Angiogenesis Analyzer from the ImageJ software. Data are presented as mean ± SEM, ^∗∗^*p* \<0.005 and ^∗^*p* \< 0.01 *versus* control, unpaired two-tail *t*-test. **(C,D)** Angiogenenic response induced by HPU on the *in vivo* CAM Assay. **(C)** Representative photomicrographs of new blood vessel formation are shown per condition (original magnification 20x). Analysis of HPU-induced angiogenesis was performed through quantification of the number of new vessels in controls and experimental conditions. **(D)** Number of new vessels in the CAM after 72 h incubation with 10 μL of 50, 100, and 500 nM HPU; PBS (negative control) and 10 μL of a 2.78 μM solution of b-FGF2 (positive control). Data regarding 12--16 fertilized eggs per condition is depicted on the box plot graph. ANOVA analysis, followed by Dunnett's multi-comparison test, demonstrated significant differences between groups. ^∗∗∗∗^*p* \< 0.0001, ^∗∗^*p* \< 0.005, and ^∗^*p* \< 0.05.](fmicb-08-01883-g003){#F3}

Further, to evaluate the role of HPU in an *in vivo* angiogenesis model we used the chick embryo CAM assay. All tested concentrations of HPU (50, 100, and 300 nM) induced a strong angiogenic response comparable to the positive control (b-FGF2) and a significantly higher angiogenic response than the negative control, as measured by the number of new blood vessels formed (**Figures [3C,D](#F3){ref-type="fig"}**). Together, the data from the *in vitro* and *in vivo* angiogenesis assays indicate that HPU can act as a pro-angiogenic factor in *H. pylori* infections.

HPU Reshapes the Expression of Angiogenic Factors
-------------------------------------------------

To characterize the angiogenic profile of gastric epithelial cells upon treatment with HPU we performed an antibody angiogenesis array, using cellular extracts of AGS cells treated with 300 nM HPU and its untreated counterparts, pooled from three independent experiments. The effect of treatment of AGS cells with HPU on the expression of molecules involved in angiogenesis was then analyzed. The increased expression of angiogenin, angiopoietin-1, angiopoietin-2, EG-VEGF, endoglin, HB-EGF, IGFBP-1, IGFBP-2, IGFBP-3, IL-1β, neuroglin-B1 (NRG1-B1) and pentraxin-3 (PTX3), well-known pro-angiogenic factors and the decrease of anti-angiogenic factors platelet factor 4 (PF4), serpin B5, serpin F1 and vasohibin, were detected in the array assay, confirming the participation of HPU in angiogenesis-related processes (**Figure [4](#F4){ref-type="fig"}**).

![Effect of HPU on the expression levels of angiogenesis-related proteins. **(A)** Angiogenic array membranes obtained with cellular extracts from AGS cells treated or untreated with 300 nM HPU for 9 h. **(B)** Profile of angiogenic factors generated from the array membranes. The values in the bar graph represent the mean of pixel density of the two spots of the array ±SEM from one experiment, using pooled cellular extracts from three independent experiments; ^∗∗∗^*p* \< 0.001 *versus* control, unpaired two-tailed *t*-test.](fmicb-08-01883-g004){#F4}

Discussion
==========

Estimates are that *H. pylori* infection accounts for 5.5% gastroduodenal cancer worldwide and for more than 60% of all gastric cancer cases ([@B9]). The infection by *H. pylori* causes damage of gastric tissues in humans, with epithelial cell cytoplasmic vacuolization and disorganization of gastric glands in the mucosa ([@B30]). Ulcers due to gastritis in *H. pylori* infected patients have a typically slow healing process ([@B2]). Previous studies using different models of endothelial cells *in vitro* have indicated that angiogenesis, a process that enhances microcirculation and is critical to recover to wounded tissue, is impaired by *H. pylori* infection ([@B28]; [@B63]). [@B28] have demonstrated that treatment of HUVECs with a water extract of *H. pylori* significantly inhibited capillary tube formation and decreased the expression of VEGF and angiopoietin.

Several damages seen in gastric tissues infected with *H. pylori* have been ascribed to the vacuolating toxin, VacA. For example, [@B63] reported that a conditioned medium obtained from a VacA-positive *H. pylori* strain inhibited bovine aortic endothelial cell functions through a VacA-dependent nitric oxide reduction mechanism. This conditioned medium reduced cell proliferation, tube formation and migration, effects that were blocked by the VacA inhibitor 5-nitro-2-(3-phenylpropylamino)benzoic acid. Moreover, no such effects were observed in cells treated with a VacA-negative *H. pylori-* or *Escherichia coli*-conditioned media ([@B63]). VacA is known to associate with lipid rafts and is internalized by gastric cells ([@B16]). Moreover, VacA is known to reach the cytoplasm and promote vacuolization and affect mitochondrial function in gastric epithelial cells by mechanisms not yet fully characterized ([@B51]).

On the other hand, other *H. pylori*-derived proteins promote angiogenesis and contribute to tumor invasiveness and growth. *H. pylori* heat shock protein 60 (HSP60) has been reported to play a role in tumor aggressiveness ([@B37]) and to display proangiogenic activity in HUVECs ([@B38]). Cyclooxygenase-2 has also been implicated in angiogenesis and tumor invasiveness due to *H. pylori* ([@B5]). Here we demonstrate that HPU, a crucial virulence factor that allows bacterial survival and colonization of gastric mucosa, also plays a role in processes that underlie tumor growth in the stomach of infected patients.

Searching for a better understanding of how HPU exerts its pro-angiogenic effects, we have monitored the cytotoxicity of the purified urease on three gastric cell lines and studied its internalization by AGS cells. Incubation with 300 nM HPU for 24 h has not interfered in cell proliferation rates or in the cell viability of AGS, Kato-III, and MKN28 cells. This is a relatively high protein concentration considering the dose range (10--500 nM) of HPU which activates other cell types, such as platelets ([@B66]) and neutrophils ([@B64]).

HPU's internalization is evident about 5 min following its addition to AGS cells. This internalization seems to be a receptor- or structure-specific process since we could observe an increased density of HPU-immunoreactive molecules in a particular region of the plasma membrane after 45 min of incubation, when most of the protein had already been endocytosed (**Figure [2B](#F2){ref-type="fig"}**). The lack of binding and internalization of HPU after treatment of AGS cells with the cholesterol scavenger mβCD indicates that specific plasma membrane regions, such as cholesterol-rich lipid rafts could be involved in this process. It has been reported that *H. pylori* takes advantage of cholesterol-rich lipid rafts to induce responses in epithelial cells, such as the activation of NF-κB and expression of IL-8 ([@B23]). Particularly relevant to *H. pylori* pathogenesis is its type IV secretion system, which delivers CagA and VacA into the gastric cell and interacts with lipid rafts ([@B57]; [@B31]).

As shown in **Figures [2C,D](#F2){ref-type="fig"}**, HPU co-localized with early endosomes, positives for the marker EEA1. Early endosomes are the first endocytic compartment to accept incoming cargo after internalization from the plasma membrane and their primary function is the sorting of internalized molecules to different intracellular locations ([@B43]).

Lamp-1 is a marker found in either late endosomes or lysosomes, as a glycoprotein present in the cytoplasmic face of these organelles ([@B8]). **Figure [2F](#F2){ref-type="fig"}** shows that 10 min after the addition of HPU to AGS cells, the protein could be localized in structures containing Lamp-1, suggesting that the urease may be directed to a degradation route. The intracellular fate of HPU beyond this point was not investigated in this study. On the other hand, as an invasive bacterium, *H. pylori* induces autophagy in gastric epithelial cells, a process that results in the sequestration of cytosolic components within double-membrane vesicles called autophagosomes ([@B61]). These vesicles fuse with lysosomes to become autophagolysosomes, in which the vesicle contents are degraded by lysosomal hydrolases. *H. pylori* was reported to modulate and subvert this process preventing the formation of autophagolysosomes, thereby allowing bacterial proliferation ([@B19]). It has also been described that *H. pylori* induces the fusion of phagosomes, generating large less-acidic compartments called megasomes, which are necessary for intracellular bacterial survival. The formation of megasomes was shown to be HPU-dependent ([@B58]). As suggested by the HPU-like immunoreactivity localized in Lamp1-positive compartments, the protein itself or fragments of it after lysosomal hydrolysis, may have a role in the regulation of the fusion of lysosomes and autophagosomes.

The strong inflammatory response of gastric epithelial cells to *H. pylori* infection results in an intense infiltration of the gastric mucosa by polymorphonuclear leukocytes, macrophages, and lymphocytes. The degree of mucosal damage correlates with the degree of neutrophil infiltration ([@B12]). *H. pylori* was shown to induce apoptosis of gastric epithelial cells both *in vivo* and *in vitro* ([@B11]). Our group has previously shown that HPU activates human neutrophils and delays their apoptosis by altering the expression of pro- and anti-apoptotic proteins ([@B64]). Here, we showed that purified HPU tested on three different gastric cancer epithelial cell lines increased their survival and inhibited apoptosis by modulation of the levels of Bcl-X~L~, an anti-apoptotic protein, and of BAD, a pro-apoptotic protein. This result goes in line with the hypothesis of a cancer promoting effect of HPU, that could add to or potentiate the action of other tumor-inducing factors produced by the bacterium.

The production of high cytokine levels by gastric cells upon *H. pylori* infection has been reported ([@B15]), accompanied by activation of matrix metalloproteinase 10 via EGFR and ERK-mediated pathways ([@B10]). To evaluate the participation of HPU in tumorigenic processes related to *H. pylori*, we investigated the role of this protein in angiogenesis by measuring the expression of molecules involved in this phenomenon using an array analysis, and *in vitro* tubulogenesis and *in vivo* angiogenesis models.

The capillary-like tube forming assay and the Chicken embryo CAM assay are two well-accepted *in vitro* and *in vivo* models in angiogenesis studies ([@B28]; [@B62]). Platelet factor-4 (PF-4/CXCL4) was reported to inhibit angiogenesis using the CAM assay ([@B42]). Studies demonstrating down-regulation of VEGF and angiopoietin receptors in HUVECs by *H. pylori* employed a capillary tube formation assay ([@B28]). Here, we showed that purified HPU induced angiogenesis in both *in vitro* and *in vivo* models. Addition to the CAM of 1--5 picomoles of HPU produced a strong angiogenic effect equivalent to that obtained for 27.8 picomoles of b-FGF2, the positive control (**Figure [3D](#F3){ref-type="fig"}**). Thus, the angiogenic stimulus provided by HPU is about 10--15-fold more potent than that of b-FGF2.

It has been shown that the array analysis of molecules participating in angiogenesis in AGS cells after treatment with 300 nM HPU led to an increased expression of pro-angiogenic factors such as angiogenin ([@B46]), angiopoietins 1 and 2 ([@B26]; [@B69]), EG-VEGF, also known as prokineticin-1 ([@B18]; [@B1]), HB-EGF ([@B25]; [@B45]), endoglin ([@B49]), IGFBP 1, 2 and 3, considered as endothelial tumor markers ([@B22]; [@B36]; [@B33]), IL-1β ([@B27]; [@B7]), NRG1-B1 ([@B17]), and PTX3 ([@B59]). The same experiment showed contrasting results regarding the expression of anti-angiogenic factors in HPU-treated AGS cells, revealing decrease in the levels of PF-4 ([@B42]; [@B65]), serpin B5 and serpin F1 ([@B6]; [@B32]), and vasohibin-1 ([@B55]).

Conclusion
==========

The set of results presented here allow us to conclude that *H. pylori*'s urease, a well-recognized virulence factor for its enzymatic property that allows bacterial survival in the stomach mucosa, displays a potent and so far overlooked pro-angiogenic activity on gastric epithelial cells. Altogether with its platelet- and neutrophil-activating properties and pro-inflammatory activity, which are independent of its enzyme nature, HPU has potential to contribute in other ways to the pathogenesis of diseases caused by *H. pylori*. The data also emphasize the multifunctional character of this protein and throw light on the need of new approaches to better understand the pathologies associated with *H. pylori*.
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:   fibroblast growth factor

CAM

:   chorioallantoic membrane model

EG-VEGF

:   endocrine gland-derived vascular endothelial growth factor

GFP

:   green fluorescent protein

HB-EGF

:   heparin- binding epidermal growth factor-like growth factor

HPU

:   *Helicobacter pylori* urease

HUVECs

:   human umbilical vascular endothelial cells

IGFBP

:   insulin-like growth factor-binding proteins

IL-1β

:   interleukin 1β

mβCD

:   methyl-β-cyclodextrin

MTT

:   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

NRG1-B1

:   neuroglin

PF-4

:   platelet factor-4

PTX3

:   pentraxin-3

TSAII

:   trypticase soy agar with 5% sheep blood

VEGF

:   vascular endothelial growth factor

[^1]: Edited by: *Wesley H. Brooks, University of South Florida, United States*

[^2]: Reviewed by: *Alejandro Piscoya, Peruvian University of Applied Sciences, Peru; Abdul Sadiq, University of Malakand, Pakistan; Christian T. K.-H. Stadtlander, Independent Researcher, United States*

[^3]: ^†^*These authors have contributed equally to this work.*

[^4]: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Microbiology
